STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more
· statnews.com · popularity 34/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at statnews.com →
Summary
India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.